“…Promote osteoblastic differentiation (Hassan et al, 2012) miR-143, miR-31 OSX Inhibit osteoblastic differentiation (Zhang et al, 2012;Li E. et al, 2014;Liu et al, 2020) miR-101, miR-132 PI3K/AKT/mTOR pathway Promote osteoblastic differentiation (Qi and Zhang, 2014) miR-17 TCF/Wnt pathway Inhibit osteoblastic differentiation (Liu et al, 2013) miR-216 PI3K/AKT pathway Promote osteoblastic differentiation (Xiao et al, 2016) miR-194 STAT1 Promote osteoblastic differentiation (Li et al, 2015) miR-96 EGFR signaling Promote osteoblastic differentiation (Yang et al, 2014) miR-23 MARK pathway Inhibit osteoblastic differentiation (Jiang et al, 2020) miR-375 RUNX2 Inhibit osteoblastic differentiation (Du et al, 2015) miR-153 BMPRII Inhibit osteoblastic differentiation (Cao et al, 2015) miR-124 DLX Inhibit osteoblastic differentiation MiR-125b OSX Inhibit osteoblastic differentiation (Chen et al, 2014) mTOR, mammalian target of rapamycin; SMAD1, SMAD Family Member 1; TGIF, transforming growth factor-β induced factor; BMP7, Bone morphogenetic protein 7; GSK3β, Glycogen synthase kinase-3β; c-Myc, MYC proto-oncogene; HMGA1, high mobility group A; PPARγ, peroxisome proliferator activated receptor γ; Spry, Sprouty; OSX, osterix; HDAC 5, histone deacetylase 5; HOXA2, Homeobox A 2; RUNX2, Runt-related transcription factor 2; DKK1, Dickkopf 1; DKK1, Dickkopf 2; Krm2, Kremen2; sFRP2, secreted frizzled-related protein 2; SOST, sclerostin; STAT1, signal transducer and activator of transcription 1; BMPRII, bone morphogenetic protein receptor II; DLX, distal-less homeobox gene.…”